DAR File No. 41811
This notice was published in the July 1, 2017, issue (Vol. 2017, No. 13) of the Utah State Bulletin.
Health, Health Care Financing, Coverage and Reimbursement Policy
Rule R414-60B
Preferred Drug List
Five-Year Notice of Review and Statement of Continuation
DAR File No.: 41811
Filed: 06/14/2017 09:36:39 AM
NOTICE OF REVIEW AND STATEMENT OF CONTINUATION
Concise explanation of the particular statutory provisions under which the rule is enacted and how these provisions authorize or require the rule:
This rule is authorized by Section 26-18-2.4 which allows the Department of Health to reimburse for certain classes of drugs on the Preferred Drug List (PDL), spells out prior authorization requirements, and sets forth prescription override exceptions. In addition, Section 26-18-3 requires the Department to implement the Medicaid drug program through administrative rules, and Section 26-1-5 grants the Department the authority to adopt these rules for implementation.
Summary of written comments received during and since the last five-year review of the rule from interested persons supporting or opposing the rule:
The Department did not receive any written or oral comments regarding this rule.
Reasoned justification for continuation of the rule, including reasons why the agency disagrees with comments in opposition to the rule, if any:
The Department will continue this rule because it implements PDL eligibility, specifies the purpose of the PDL in relation to certain classes of drugs, clarifies that coverage is based on clinical and cost effectiveness, spells out prior authorization requirements, implements Pharmacy and Therapeutics (P&T) Committee composition and membership, implements P&T Committee responsibilities and functions, and sets forth provisions for the P&T Committee to make determinations based on clinical and cost-related factors.
The full text of this rule may be inspected, during regular business hours, at the Office of Administrative Rules, or at:
HealthHealth Care Financing, Coverage and Reimbursement Policy
CANNON HEALTH BLDG
288 N 1460 W
SALT LAKE CITY, UT 84116-3231
Direct questions regarding this rule to:
- Craig Devashrayee at the above address, by phone at 801-538-6641, by FAX at 801-538-6099, or by Internet E-mail at [email protected]
Effective:
06/14/2017
Authorized by:
Joseph Miner, Executive Director
Additional Information
More information about a Five-Year Notice of Review and Statement of Continuation is available online.
The Portable Document Format (PDF) version of the Bulletin is the official version. The PDF version of this issue is available at https://rules.utah.gov/publicat/bull_pdf/2017/b20170701.pdf. The HTML edition of the Bulletin is a convenience copy. Any discrepancy between the PDF version and HTML version is resolved in favor of the PDF version.
For questions regarding the content or application of this rule, please contact Craig Devashrayee at the above address, by phone at 801-538-6641, by FAX at 801-538-6099, or by Internet E-mail at [email protected]. For questions about the rulemaking process, please contact the Office of Administrative Rules.